Division of Radiation Health, Department of Pharmaceutical Sciences, University of Arkansas for Medical Sciences, 4301 West Markham, Slot 522-10, Little Rock, AR 72205, USA.
Cardiol Res Pract. 2010 Oct 4;2011:858262. doi: 10.4061/2011/858262.
Radiation-induced heart disease (RIHD) is a potentially severe side effect of radiotherapy of thoracic and chest wall tumors if all or part of the heart was included in the radiation field. RIHD presents clinically several years after irradiation and manifestations include accelerated atherosclerosis, pericardial and myocardial fibrosis, conduction abnormalities, and injury to cardiac valves. There is no method to prevent or reverse these injuries when the heart is exposed to ionizing radiation. This paper presents an overview of recent studies that address the role of microvascular injury, endothelial dysfunction, mast cells, and the renin angiotensin system in animal models of cardiac radiation injury. These insights into the basic mechanisms of RIHD may lead to the identification of targets for intervention in this late radiotherapy side effect.
放射性心脏病(RIHD)是胸部和胸壁肿瘤放疗的一种潜在严重的副作用,如果心脏的全部或部分包括在照射野内。RIHD 在照射后数年出现临床症状,表现为动脉粥样硬化加速、心包和心肌纤维化、传导异常以及心脏瓣膜损伤。当心脏暴露于电离辐射时,没有方法可以预防或逆转这些损伤。本文综述了最近的一些研究,这些研究探讨了微血管损伤、内皮功能障碍、肥大细胞和肾素血管紧张素系统在心脏放射损伤动物模型中的作用。这些对 RIHD 基本机制的认识可能会导致确定针对这种晚期放射治疗副作用的干预靶点。